Li-Yan Khor

Supplementary Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Alan S Pollack, Kyounghwa Bae, Li-Yan Khor, Tahseen Al‐Saleem et autres

Supplementary Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Alan S Pollack, Kyounghwa Bae, Li-Yan Khor, Tahseen Al‐Saleem et autres

Abstract Purpose: We previously reported that protein kinase A type I (PKARIα) overexpression was predictive of outcome in prostate cancer patients treated with radiotherapy (RT) ± short-term androgen deprivation (STAD) on Radiation Therapy Oncology Group (RTOG) protocol 86-10. Here, we attempt to …

Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Alan S Pollack, Kyounghwa Bae, Li-Yan Khor, Tahseen Al‐Saleem et autres

Abstract Purpose: We previously reported that protein kinase A type I (PKARIα) overexpression was predictive of outcome in prostate cancer patients treated with radiotherapy (RT) ± short-term androgen deprivation (STAD) on Radiation Therapy Oncology Group (RTOG) protocol 86-10. Here, we attempt to …

Supplementary Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Alan S Pollack, Kyounghwa Bae, Li-Yan Khor, Tahseen Al‐Saleem et autres

Supplementary Data from The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02

Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer

Lui Shiong Lee, Adelene Y. L. Sim, Chee Wee Ong, Xinyan Yang et autres

Correction to: Prostate Cancer and Prostatic Diseases https://doi.org/10.1038/s41391-022-00496-8 , published online 28 January 2022

sg (code pays fourni par la source)

A promising deep learning-assistive algorithm for histopathological screening of colorectal cancer

Cowan Ho, Zitong Zhao, Xiu Fen Chen, Jan Sauer et autres

Colorectal cancer is one of the most common cancers worldwide, accounting for an annual estimated 1.8 million incident cases. With the increasing number of colonoscopies being performed, colorectal biopsies make up a large proportion of any histopathology laboratory workload. We trained and …

sg (code pays fourni par la source)

NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer

Lui Shiong Lee, Adelene Y. L. Sim, Chee Wee Ong, Xinyan Yang et autres

OBJECTIVE: Treatment efficacy of androgen deprivation therapy with radical prostatectomy for intermediate- to high-risk prostate cancer is less well-studied. The NEAR trial is a single-arm, phase II investigation of neoadjuvant apalutamide monotherapy and radical prostatectomy (RP) in the treatment of D'Amico intermediate- …

sg (code pays fourni par la source)

218MO Comparison of a 22-gene genomic classifier (GC) with NCCN for risk stratification of Asian prostate cancers (PCa)

W. Wai Yee, Adelene Y. L. Sim, Kar Perng Low, Alice X. Meng et autres

sg, us (code pays fourni par la source)

Pap Tests with Co-existing Squamous and Glandular Lesions: A Single Institutional Experience with Histologic Follow-up

Li-Yan Khor, Fadi W. Abdul‐Karim, Amanda E. Bruening, Dana Weber et autres

us (code pays fourni par la source)

Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression

Xu-Zhi Xu, Marileila Varella Garcia, Tianyu Li, Li-Yan Khor et autres

us (code pays fourni par la source)

A Model for Distant Metastasis Incorporating Tissue Biomarkers from Prostate Cancer Patients in Radiation Therapy Oncology Group (RTOG) 92-02

Alan S Pollack, K. Bae, Li-Yan Khor, Elizabeth H. Hammond et autres

us (code pays fourni par la source)

Evaluation of Ki-67 Expression as an Independent Biomarker of Biochemical Failure Following Salvage Radiation Therapy for Prostate Cancer

Steven J. Buskirk, Alex Michael Parker, Michael G. Heckman, Julia E. Crook et autres

us (code pays fourni par la source)